| Article
| Article
If you have chronic arthritis pain, you may be wondering about cannabidiol (CBD) as a treatment. CBD, along with delta-9-tetrahydrocannabinol (THC) and other chemicals, is found in marijuana. But unlike THC, CBD is not “psychoactive” — that is, it does not cause the intoxication or high associated...
| Article
Newswise — Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a...
| Article
Newswise — McMaster University researchers have identified an antibacterial compound made by cannabis plants that may serve as a lead for new drug development.
An interdisciplinary team of McMaster researchers found that the chemical compound, or cannabinoid, called cannabigerol (CBG) is not only...
| Article
Newswise — Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.
The study, published online recently in the Journal of Pain, is the...
| Article
Newswise — A team of researchers at the University of Georgia will study how legalized medical cannabis affects people living with chronic pain.
To date, 34 states and the District of Columbia have adopted medical cannabis laws, or MCLs, which legalize either home cultivation or dispensary-based...
| Podcast
Skin conditions can be painful too. We are fortunate to have CBD and other cannabinoids as well as THC for many skin conditions including acne, itch, eczema, psoriasis, and wounds of all sorts. The cannabinoids help not only with the signs and symptoms of the dermatologic problem, but also help...
| Article
As has been frequently noted by different contributors to the PAINWeek platform, there is a range of opinion on the safety and efficacy of medical cannabis, brought on in no small part by the dearth of clinical study resulting from current federal regulatory status. New research from the University...
| Article
A research team composed of members from China, Russia, and the US have announced a significant advance in understanding the structure of CB2, one of 2 cannabinoid receptors in the human endocannabinoid system. Cannabinoid receptors can be targeted to address a range of pathological conditions...
| Article
The use of cannabis is big business in the United States and internationally, so we’re dealing a lot with cannabis in terms of both medicinal and recreational applications. What does that mean? I really think that clinicians now need to be encouraged to educate themselves about what is known and...
Pagination
- Previous page
- Page 2
- Next page